Halozyme Therapeutics, Inc.
$HALO
Public valuation for Halozyme Therapeutics, Inc. (HALO). Fair value, signal, and key metrics — no sign-in required.
Current Price
$78.27
84% Undervalued
Fair Value Estimate
$144
💎
Value
Established company trading at a low multiple
Analyst Consensus
Target: $83.90
7% higher than current
Key Metrics
Market Cap
$9.3B
Forward P/E
10.4x
Operating Margin
49.0%
Revenue Growth
38.7%
PEG Ratio
0.78
Get free watchlist alerts
Join the waitlist for valuation updates on $HALO and the rest of your watchlist.
Join the waitlistJoin the waitlist
Stay on this page to join — no sign-in required.